e 4031 has been researched along with Heart Disease, Ischemic in 5 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, JY | 1 |
| Cheng, K | 1 |
| Lai, D | 1 |
| Kong, LH | 1 |
| Shen, M | 1 |
| Yi, F | 1 |
| Liu, B | 1 |
| Wu, F | 2 |
| Zhou, JJ | 2 |
| Li, SZ | 1 |
| Wang, B | 1 |
| Wei, GZ | 1 |
| Jin, ZX | 1 |
| Zang, YM | 1 |
| Wong, TM | 1 |
| McIntosh, MA | 1 |
| Tanira, M | 1 |
| Pacini, D | 1 |
| Kane, KA | 1 |
| MacKenzie, I | 1 |
| Saville, VL | 1 |
| Waterfall, JF | 1 |
| Veldkamp, MW | 1 |
| van Ginneken, AC | 1 |
| Opthof, T | 1 |
| Bouman, LN | 1 |
5 other studies available for e 4031 and Heart Disease, Ischemic
| Article | Year |
|---|---|
Cardiac sodium/calcium exchanger preconditioning promotes anti-arrhythmic and cardioprotective effects through mitochondrial calcium-activated potassium channel.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Ischemic Preconditioning; Male; Mitochondria; | 2015 |
Role of reverse mode Na+/Ca2+ exchanger in the cardioprotection of metabolic inhibition preconditioning in rat ventricular myocytes.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Cell Survival; Fura-2; Ischemic Preconditioning, Myocardia | 2007 |
Comparison of the cardiac electrophysiologic effects of NE-10064 with sotalol and E-4031 and their modification by simulated ischaemia.
Topics: Animals; Anti-Arrhythmia Agents; Hydantoins; Imidazoles; Imidazolidines; In Vitro Techniques; Myocar | 1994 |
Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Electrophysiology; Glyburide; Guinea Pigs; Heart | 1993 |
Delayed rectifier channels in human ventricular myocytes.
Topics: Action Potentials; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cells, Cultured; Heart Ventricle | 1995 |